Publications

Publications search (many options)

Publika data base

Publications (original articles or review articles) published in 2013 from OUS - Department of Nephrology Rikshospitalet (Div CMST)

22 publications found

Berdal M, Jenssen T (2013)
No Association between Glycemia and Wound Healing in an Experimental db/db Mouse Model
ISRN Endocrinol, 2013, 307925
PubMed 24251043

Bethel MA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Kahn SE, Levitt NS, McMurray JJ, Califf RM, Raptis SA, Thomas L, Sun JL, Haffner SM (2013)
A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk
Am J Cardiol, 112 (2), 231-7
PubMed 23608615

Dahle DO, Jenssen T, Holdaas H, Leivestad T, Vårdal M, Mjøen G, Reisaeter AV, Toft I, Hartmann A (2013)
Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients
Clin Transplant, 28 (1), 134-40
PubMed 24372653

Dahle DO, Midtvedt K, Hartmann A, Jenssen T, Holdaas H, Mjøen G, Leivestad T, Asberg A (2013)
Endothelial dysfunction is associated with graft loss in renal transplant recipients
Transplantation, 95 (5), 733-9
PubMed 23364481

Dörje C, Midtvedt K, Holdaas H, Naper C, Strøm EH, Øyen O, Leivestad T, Aronsen T, Jenssen T, Flaa-Johnsen L, Lindahl JP, Hartmann A, Reisæter AV (2013)
Early versus late acute antibody-mediated rejection in renal transplant recipients
Transplantation, 96 (1), 79-84
PubMed 23632391

Flechner SM, Gurkan A, Hartmann A, Legendre CM, Russ GR, Campistol JM, Schena FP, Hahn CM, Li H, Korth-Bradley JM, Tai SS, Schulman SL (2013)
A randomized, open-label study of sirolimus versus cyclosporine in primary de novo renal allograft recipients
Transplantation, 95 (10), 1233-41
PubMed 23689085

Heldal K, Midtvedt K (2013)
Managing transplant rejection in the elderly: the benefits of less aggressive immunosuppressive regimens
Drugs Aging, 30 (7), 459-66
PubMed 23609876

Heldal K, Thorarinsdottir S, Hartmann A, Leivestad T, Reisæter AV, Foss AE, Midtvedt K (2013)
Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study
Transplant Res, 2 (1), 11
PubMed 23799993

Hornum M, Lindahl JP, von Zur-Mühlen B, Jenssen T, Feldt-Rasmussen B (2013)
Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation Societies
Transpl Int, 26 (11), 1049-60
PubMed 23634804

Knoop T, Vikse BE, Svarstad E, Leh S, Reisæter AV, Bjørneklett R (2013)
Mortality in patients with IgA nephropathy
Am J Kidney Dis, 62 (5), 883-90
PubMed 23796906

Lindahl JP, Hartmann A, Horneland R, Holdaas H, Reisæter AV, Midtvedt K, Leivestad T, Oyen O, Jenssen T (2013)
Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease
Diabetologia, 56 (6), 1364-71
PubMed 23549518

Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Øvrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H (2013)
Long-term risks for kidney donors
Kidney Int, 86 (1), 162-7
PubMed 24284516

Pihlstrøm H, Mjøen G, März W, Olav Dahle D, Abedini S, Holme I, Fellström B, Jardine A, Pilz S, Holdaaas H (2013)
Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients
Clin Transplant, 28 (1), 111-9
PubMed 24372612

Reine TM, Grøndahl F, Jenssen TG, Hadler-Olsen E, Prydz K, Kolset SO (2013)
Reduced sulfation of chondroitin sulfate but not heparan sulfate in kidneys of diabetic db/db mice
J Histochem Cytochem, 61 (8), 606-16
PubMed 23757342

Schjelderup P, Dahle DO, Holdaas H, Mjøen G, Nordby G, Abedini S, Jardine A, Fellström B, Svensson M (2013)
Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study
Clin Transplant, 27 (6), E636-43
PubMed 23991916

Schneider A, Jardine AG, Schneider MP, Holdaas H, Holme I, Fellstroem BC, Zannad F, Schmieder RE, AURORA Study Group (2013)
Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study
Am J Nephrol, 37 (2), 144-51
PubMed 23392089

Smedbråten YV, Sagedal S, Leivestad T, Mjøen G, Osnes K, Rollag H, Reisaeter AV, Foss A, Os I, Hartmann A (2013)
The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
Clin Transplant, 28 (1), 120-6
PubMed 24351078

Soveri I, Snyder J, Holdaas H, Holme I, Jardine AG, L'Italien GJ, Fellström B (2013)
The external validation of the cardiovascular risk equation for renal transplant recipients: applications to BENEFIT and BENEFIT-EXT trials
Transplantation, 95 (1), 142-7
PubMed 23192156

Storhaug HM, Norvik JV, Toft I, Eriksen BO, Løchen ML, Zykova S, Solbu M, White S, Chadban S, Jenssen T (2013)
Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study
BMC Cardiovasc Disord, 13, 115
PubMed 24330812

Størset E, Holford N, Midtvedt K, Bremer S, Bergan S, Åsberg A (2013)
Importance of hematocrit for a tacrolimus target concentration strategy
Eur J Clin Pharmacol, 70 (1), 65-77
PubMed 24071959

Åsberg A, Apeland T, Reisaeter AV, Foss A, Leivestad T, Heldal K, Thorud LO, Eriksen BO, Hartmann A, NILS Study Group (2013)
Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial
Clin Transplant, 27 (2), E151-6
PubMed 23351013

Åsberg A, Midtvedt K, van Guilder M, Størset E, Bremer S, Bergan S, Jelliffe R, Hartmann A, Neely MN (2013)
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
Transpl Int, 26 (12), 1198-207
PubMed 24118301